Express Scripts’ New 340B Claims ID Requirement Has Covered Entities Worried

The 340B Coalition told Express Scripts that covered entities cannot comply with its new 340B claims submission and identification requirement absent "a massive investment of financial and human resources." | Shutterstock

Pharmacy benefit manager Express Scripts late yesterday began notifying 340B covered entities by email that, effective March 1, it “will require a new identification method for submitting and identifying 340B eligible claims.”

A health system 340B program manager said this

Read More »

HHS-Designate Becerra May Face 340B Questions Today During First Nomination Hearing

HHS-Secretary designate Xavier Becerra could face questions about the 340B program today during his first of two Senate nomination hearings this week.

The U.S. Senate Health, Education, Labor, and Pensions (HELP) Committee this morning is holding the first of two Senate committee hearings this week on President Biden’s nomination of California Attorney General Xavier Becerra to serve as U.S. Health and Human

Read More »

Biden Staffs Up with 340B Policy Experts in Key Positions

President Biden is bringing a number of 340B policy experts on board to his team. Yesterday, he formally nominated Andrea Palm, most recently Wisconsin’s health secretary-designate, to be U.S. Deputy Secretary of Health and Human Services (HHS). Palm would be

Read More »

HRSA Allows 340B Enrollment Flexibility in Storm-Battered Texas

A Feb. 13-17 winter storm caused mass power outages and water and food shortages in Texas.

The U.S. Health Resources and Services Administration (HRSA), in light of the declared public health emergency in Texas, is letting eligible health care providers there enroll immediately in the 340B drug pricing program instead of waiting for the next normal

Read More »

AEH Asks Biden to Prioritize Three 340B-Related Issues

America's Essential Hospitals wants the Biden administration to reverse Trump administration policies that its says harm and the 340B program and are contrary to congressional intent. | Facebook

The Biden administration should reverse “harmful Trump administration policies” that “undermined the 340B program and contravened Congress’ intent,” the group America’s Essential Hospitals advised President Biden in a letter earlier this month.

America’s Essential Hospitals’ Feb. 10 letter said

Read More »

Senate Hearings Next Week on Becerra’s Nomination to Head HHS

The Senate Finance and HELP committees will hold hearings next week on Xavier Becerra's nomination to serve as HHS Secretary.

Two U.S. Senate committees have scheduled hearings next week on President Biden’s nomination of California Attorney General Xavier Becerra to be the next U.S. Health and Human Services (HHS) Secretary. In December, Becerra helped spearhead a bipartisan letter of

Read More »

Biden Reportedly Has Settled on His Choice to Run CMS

President Biden reportedly has chosen former federal executive and legislative branch health policy official Chiquita Brooks-LaSure to be his nominee to head CMS.

Several news organizations report that the Biden administration will nominate former federal executive and legislative branch health policy official Chiquita Brooks-LaSure to serve as Administrator of the Center for Medicare & Medicaid Services (CMS). The White House had not announced

Read More »

Generic Drug Manufacturer Posts 340B Refund Notice

Generic liquid drug manufacturer Pharmaceutical Associates, Inc. (PAI), has notified 340B covered entities on the U.S. Health Resources and Services Administration (HRSA) website about 340B overcharges and potential credit/rebill repayments regarding all of its products covering the first through third

Read More »

Muted by Litigation, Pedley Avoids Hottest 340B Topics But Provides Some Nuggets

The U.S. Health Resources and Services Administration (HRSA) is “ramping up” its work with the Biden administration “and bringing forth the key issues and concerns of” the 340B program, Rear Adm. Krista Pedley, the program’s director, said today in a

Read More »

PolitiFact Calls Senate Candidate’s 340B Insulin Claim “Mostly False”

PolitiFact rated U.S. Senate candidate Mark Walker’s tweet that President Biden “is raising the prices of insulin and Epi-Pens on those with high costs and the uninsured” as being Mostly False.

A Pulitzer Prize-winning journalism website that fact-checks politicians’ claims has waded into the controversy over whether President Biden raised insulin prices by freezing a 340B-related Trump administration regulation.

On Feb. 11, the Poynter Institute’s PolitiFact site rated U.S. Senate

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live